ABBV Stock Up 5% on Robust Q1 Performance: Time to Buy, Sell or Hold?

AbbVie ABBV stock has risen around 5% since it announced robust first-quarter 2026 results on April 29. It beat estimates for both earnings and sales and the guidance for 2026 revenues and earnings was also raised.